Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-03-20

AUTHORS

Arefeh Shafie, Maryam Mohammadi-Khanaposhtani, Mehdi Asadi, Nastaran Rahimi, Parviz Rashidi Ranjbar, Jahan B. Ghasemi, Bagher Larijani, Mohammad Mahdavi, Hamed Shafaroodi, Ahmad Reza Dehpour

ABSTRACT

A novel series of 1,2,3-triazolo-benzodiazepine derivatives 6a-o has been synthesized and evaluated in vivo for their anticonvulsant activities using by pentylenetetrazole (PTZ)- and maximal electroshock (MES)-induced seizures in mice. The synthetic approach started with diazotizing 2-aminobenzoic acids 1 to produce 2-azidobenzoic acids 2. Next, reaction of the latter compounds with propargylamine 3, benzaldehyde 4, and isocyanides 5 led to the formation of the title compounds 6a-o, in good yields. All the synthesized compounds exhibited high anticonvulsant activity in the PTZ test, comparable to or better than the standard drug diazepam. Among the tested compounds, N-(tert-butyl)-2-(9-chloro-6-oxo-4H-[1,2,3]triazolo[1,5-a][1,4]benzodiazepin-5(6H)-yl)-2-(3-bromophenyl)acetamide 6h was the most potent compound in this assay. Moreover, compounds 6i and 6k showed excellent activity in MES test. Loss of the anticonvulsant effect of compound 6h in the presence of flumazenil in the PTZ test and appropriate interaction of this compound in the active site of benzodiazepine (BZD)-binding site of GABAA receptor confirm involvement of BZD receptors in the anticonvulsant activity of compound 6h. A novel series of 1,2,3-triazolo-benzodiazepine derivatives 6a-o have been synthesized and evaluated in vivo for their anticonvulsant activities using by pentylenetetrazole (PTZ)- and maximal electroshock (MES)-induced seizures in mice. All the synthesized compounds exhibited high anticonvulsant activity, comparable to or better than the standard drug diazepam in the PTZ test and compounds 6i and 6k showed excellent activity in MES test. Flumazenil test and in silico docking study confirm involvement of benzodiazepine receptors in the anticonvulsant activity of these compounds. More... »

PAGES

1-11

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11030-019-09940-9

DOI

http://dx.doi.org/10.1007/s11030-019-09940-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112900119

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30895449


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Tehran", 
          "id": "https://www.grid.ac/institutes/grid.46072.37", 
          "name": [
            "School of Chemistry, College of Science, University of Tehran, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shafie", 
        "givenName": "Arefeh", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Babol University of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.411495.c", 
          "name": [
            "Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mohammadi-Khanaposhtani", 
        "givenName": "Maryam", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tehran University of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.411705.6", 
          "name": [
            "Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Asadi", 
        "givenName": "Mehdi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tehran University of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.411705.6", 
          "name": [
            "Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rahimi", 
        "givenName": "Nastaran", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tehran", 
          "id": "https://www.grid.ac/institutes/grid.46072.37", 
          "name": [
            "School of Chemistry, College of Science, University of Tehran, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ranjbar", 
        "givenName": "Parviz Rashidi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tehran", 
          "id": "https://www.grid.ac/institutes/grid.46072.37", 
          "name": [
            "School of Chemistry, College of Science, University of Tehran, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghasemi", 
        "givenName": "Jahan B.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tehran University of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.411705.6", 
          "name": [
            "Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larijani", 
        "givenName": "Bagher", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tehran University of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.411705.6", 
          "name": [
            "Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mahdavi", 
        "givenName": "Mohammad", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tehran University of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.411705.6", 
          "name": [
            "Department of Pharmacology, Tehran University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shafaroodi", 
        "givenName": "Hamed", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tehran University of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.411705.6", 
          "name": [
            "Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran", 
            "Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dehpour", 
        "givenName": "Ahmad Reza", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1021/ol1028404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001695760"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/ol1028404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001695760"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1098-1128(199711)17:6<537::aid-med3>3.0.co;2-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005491171"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tet.2013.02.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005922223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejmech.2016.01.054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005941300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejmech.2016.01.054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005941300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejmech.2016.01.054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005941300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejmech.2016.01.054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005941300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bmcl.2009.06.107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007534061"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tet.2014.07.050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014743949"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0404.2008.01004.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014848369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.farmac.2003.11.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017072338"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejmech.2010.02.063", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024759393"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejmech.2005.12.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025275759"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(75)90501-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032239637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(75)90501-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032239637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tet.2015.06.060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035717697"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejmech.2011.09.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036829595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1179/1743132812y.0000000080", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046589525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0014-2999(97)01514-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050401468"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0032-1317297", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057266376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4088/jcp.v64n0107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072208358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jksus.2018.02.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101297005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bioorg.2018.03.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101366494"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-03-20", 
    "datePublishedReg": "2019-03-20", 
    "description": "A novel series of 1,2,3-triazolo-benzodiazepine derivatives 6a-o has been synthesized and evaluated in vivo for their anticonvulsant activities using by pentylenetetrazole (PTZ)- and maximal electroshock (MES)-induced seizures in mice. The synthetic approach started with diazotizing 2-aminobenzoic acids 1 to produce 2-azidobenzoic acids 2. Next, reaction of the latter compounds with propargylamine 3, benzaldehyde 4, and isocyanides 5 led to the formation of the title compounds 6a-o, in good yields. All the synthesized compounds exhibited high anticonvulsant activity in the PTZ test, comparable to or better than the standard drug diazepam. Among the tested compounds, N-(tert-butyl)-2-(9-chloro-6-oxo-4H-[1,2,3]triazolo[1,5-a][1,4]benzodiazepin-5(6H)-yl)-2-(3-bromophenyl)acetamide 6h was the most potent compound in this assay. Moreover, compounds 6i and 6k showed excellent activity in MES test. Loss of the anticonvulsant effect of compound 6h in the presence of flumazenil in the PTZ test and appropriate interaction of this compound in the active site of benzodiazepine (BZD)-binding site of GABAA receptor confirm involvement of BZD receptors in the anticonvulsant activity of compound 6h. A novel series of 1,2,3-triazolo-benzodiazepine derivatives 6a-o have been synthesized and evaluated in vivo for their anticonvulsant activities using by pentylenetetrazole (PTZ)- and maximal electroshock (MES)-induced seizures in mice. All the synthesized compounds exhibited high anticonvulsant activity, comparable to or better than the standard drug diazepam in the PTZ test and compounds 6i and 6k showed excellent activity in MES test. Flumazenil test and in silico docking study confirm involvement of benzodiazepine receptors in the anticonvulsant activity of these compounds.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11030-019-09940-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1114785", 
        "issn": [
          "1381-1991", 
          "1573-501X"
        ], 
        "name": "Molecular Diversity", 
        "type": "Periodical"
      }
    ], 
    "name": "Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations", 
    "pagination": "1-11", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a77a7215c3e0aefe6a30a349de2e24c1ca9cb6f034125fbdddab80d452d791f2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30895449"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9516534"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11030-019-09940-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112900119"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11030-019-09940-9", 
      "https://app.dimensions.ai/details/publication/pub.1112900119"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70037_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11030-019-09940-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11030-019-09940-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11030-019-09940-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11030-019-09940-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11030-019-09940-9'


 

This table displays all metadata directly associated to this object as RDF triples.

183 TRIPLES      21 PREDICATES      45 URIs      18 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11030-019-09940-9 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author N21dea68105ce4191b6dd9d18ecd4e22c
4 schema:citation https://doi.org/10.1002/(sici)1098-1128(199711)17:6<537::aid-med3>3.0.co;2-2
5 https://doi.org/10.1016/0024-3205(75)90501-9
6 https://doi.org/10.1016/j.bioorg.2018.03.001
7 https://doi.org/10.1016/j.bmcl.2009.06.107
8 https://doi.org/10.1016/j.ejmech.2005.12.003
9 https://doi.org/10.1016/j.ejmech.2010.02.063
10 https://doi.org/10.1016/j.ejmech.2011.09.021
11 https://doi.org/10.1016/j.ejmech.2016.01.054
12 https://doi.org/10.1016/j.farmac.2003.11.013
13 https://doi.org/10.1016/j.jksus.2018.02.009
14 https://doi.org/10.1016/j.tet.2013.02.023
15 https://doi.org/10.1016/j.tet.2014.07.050
16 https://doi.org/10.1016/j.tet.2015.06.060
17 https://doi.org/10.1016/s0014-2999(97)01514-8
18 https://doi.org/10.1021/ol1028404
19 https://doi.org/10.1055/s-0032-1317297
20 https://doi.org/10.1111/j.1600-0404.2008.01004.x
21 https://doi.org/10.1179/1743132812y.0000000080
22 https://doi.org/10.4088/jcp.v64n0107
23 schema:datePublished 2019-03-20
24 schema:datePublishedReg 2019-03-20
25 schema:description A novel series of 1,2,3-triazolo-benzodiazepine derivatives 6a-o has been synthesized and evaluated in vivo for their anticonvulsant activities using by pentylenetetrazole (PTZ)- and maximal electroshock (MES)-induced seizures in mice. The synthetic approach started with diazotizing 2-aminobenzoic acids 1 to produce 2-azidobenzoic acids 2. Next, reaction of the latter compounds with propargylamine 3, benzaldehyde 4, and isocyanides 5 led to the formation of the title compounds 6a-o, in good yields. All the synthesized compounds exhibited high anticonvulsant activity in the PTZ test, comparable to or better than the standard drug diazepam. Among the tested compounds, N-(tert-butyl)-2-(9-chloro-6-oxo-4H-[1,2,3]triazolo[1,5-a][1,4]benzodiazepin-5(6H)-yl)-2-(3-bromophenyl)acetamide 6h was the most potent compound in this assay. Moreover, compounds 6i and 6k showed excellent activity in MES test. Loss of the anticonvulsant effect of compound 6h in the presence of flumazenil in the PTZ test and appropriate interaction of this compound in the active site of benzodiazepine (BZD)-binding site of GABA<sub>A</sub> receptor confirm involvement of BZD receptors in the anticonvulsant activity of compound 6h. A novel series of 1,2,3-triazolo-benzodiazepine derivatives 6a-o have been synthesized and evaluated in vivo for their anticonvulsant activities using by pentylenetetrazole (PTZ)- and maximal electroshock (MES)-induced seizures in mice. All the synthesized compounds exhibited high anticonvulsant activity, comparable to or better than the standard drug diazepam in the PTZ test and compounds 6i and 6k showed excellent activity in MES test. Flumazenil test and in silico docking study confirm involvement of benzodiazepine receptors in the anticonvulsant activity of these compounds.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf sg:journal.1114785
30 schema:name Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations
31 schema:pagination 1-11
32 schema:productId N12d4c1f226094bda896ea0523ff433e1
33 N1f29e2e1d7314576a3449b50b934c8ab
34 N2d3abe0c0d9645f99dfde616bf13c9a8
35 N82d65d1cd7d242f6b1ab89f0917d4ae1
36 Nabf29017a3704a1f8f3bc284155ded77
37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112900119
38 https://doi.org/10.1007/s11030-019-09940-9
39 schema:sdDatePublished 2019-04-11T12:38
40 schema:sdLicense https://scigraph.springernature.com/explorer/license/
41 schema:sdPublisher Nf705923e75654831b0d2643a91bd56c0
42 schema:url https://link.springer.com/10.1007%2Fs11030-019-09940-9
43 sgo:license sg:explorer/license/
44 sgo:sdDataset articles
45 rdf:type schema:ScholarlyArticle
46 N12d4c1f226094bda896ea0523ff433e1 schema:name dimensions_id
47 schema:value pub.1112900119
48 rdf:type schema:PropertyValue
49 N17e004fac3174865af50f9b63e3380a4 rdf:first N19b4d4b294e9410da59abef1c0222deb
50 rdf:rest Ncae8e5bd64c94e939b93e6e2d027ac82
51 N19b4d4b294e9410da59abef1c0222deb schema:affiliation https://www.grid.ac/institutes/grid.46072.37
52 schema:familyName Ranjbar
53 schema:givenName Parviz Rashidi
54 rdf:type schema:Person
55 N1f29e2e1d7314576a3449b50b934c8ab schema:name nlm_unique_id
56 schema:value 9516534
57 rdf:type schema:PropertyValue
58 N21dea68105ce4191b6dd9d18ecd4e22c rdf:first N3dafea4dddc3439aa235753eefb38090
59 rdf:rest Ncd323b15cce1470c9f30264a94df4b5c
60 N2692fbef497e488e8a5e5d08a52351c6 rdf:first N8a2a8638f23f45a981fec591ed2313d1
61 rdf:rest N9ea41f3c053242708cddbe03039ca4ce
62 N2d3abe0c0d9645f99dfde616bf13c9a8 schema:name doi
63 schema:value 10.1007/s11030-019-09940-9
64 rdf:type schema:PropertyValue
65 N3ba7c6199e334f289f917a51c99f1d85 rdf:first Nce64b19986da4d90a2e2d56791ecb436
66 rdf:rest Ne834b156573b41f39cd22a135002899e
67 N3dafea4dddc3439aa235753eefb38090 schema:affiliation https://www.grid.ac/institutes/grid.46072.37
68 schema:familyName Shafie
69 schema:givenName Arefeh
70 rdf:type schema:Person
71 N78278f3c7afc4347a71b0f37f612e112 schema:affiliation https://www.grid.ac/institutes/grid.411705.6
72 schema:familyName Rahimi
73 schema:givenName Nastaran
74 rdf:type schema:Person
75 N813b2923eddc4b71b85f04fb2ce4ad39 schema:affiliation https://www.grid.ac/institutes/grid.411705.6
76 schema:familyName Dehpour
77 schema:givenName Ahmad Reza
78 rdf:type schema:Person
79 N82d65d1cd7d242f6b1ab89f0917d4ae1 schema:name readcube_id
80 schema:value a77a7215c3e0aefe6a30a349de2e24c1ca9cb6f034125fbdddab80d452d791f2
81 rdf:type schema:PropertyValue
82 N8a2a8638f23f45a981fec591ed2313d1 schema:affiliation https://www.grid.ac/institutes/grid.411705.6
83 schema:familyName Asadi
84 schema:givenName Mehdi
85 rdf:type schema:Person
86 N9ea41f3c053242708cddbe03039ca4ce rdf:first N78278f3c7afc4347a71b0f37f612e112
87 rdf:rest N17e004fac3174865af50f9b63e3380a4
88 N9f494f5cf2024ef8b24d0921eff39bcd schema:affiliation https://www.grid.ac/institutes/grid.411705.6
89 schema:familyName Larijani
90 schema:givenName Bagher
91 rdf:type schema:Person
92 Na170ce4bcfc94818bb3a3a5499b356e3 rdf:first N9f494f5cf2024ef8b24d0921eff39bcd
93 rdf:rest N3ba7c6199e334f289f917a51c99f1d85
94 Nabf29017a3704a1f8f3bc284155ded77 schema:name pubmed_id
95 schema:value 30895449
96 rdf:type schema:PropertyValue
97 Nc440099defe54e03ba25310aa4858c62 rdf:first N813b2923eddc4b71b85f04fb2ce4ad39
98 rdf:rest rdf:nil
99 Nc46906301c0b4f32bbd679c851b9b3d0 schema:affiliation https://www.grid.ac/institutes/grid.46072.37
100 schema:familyName Ghasemi
101 schema:givenName Jahan B.
102 rdf:type schema:Person
103 Ncae8e5bd64c94e939b93e6e2d027ac82 rdf:first Nc46906301c0b4f32bbd679c851b9b3d0
104 rdf:rest Na170ce4bcfc94818bb3a3a5499b356e3
105 Ncd323b15cce1470c9f30264a94df4b5c rdf:first Nf4122f26f9014b3e8cf9bf04959f758f
106 rdf:rest N2692fbef497e488e8a5e5d08a52351c6
107 Nce64b19986da4d90a2e2d56791ecb436 schema:affiliation https://www.grid.ac/institutes/grid.411705.6
108 schema:familyName Mahdavi
109 schema:givenName Mohammad
110 rdf:type schema:Person
111 Ndd35e2eccb75494baaff1f0d55c0c916 schema:affiliation https://www.grid.ac/institutes/grid.411705.6
112 schema:familyName Shafaroodi
113 schema:givenName Hamed
114 rdf:type schema:Person
115 Ne834b156573b41f39cd22a135002899e rdf:first Ndd35e2eccb75494baaff1f0d55c0c916
116 rdf:rest Nc440099defe54e03ba25310aa4858c62
117 Nf4122f26f9014b3e8cf9bf04959f758f schema:affiliation https://www.grid.ac/institutes/grid.411495.c
118 schema:familyName Mohammadi-Khanaposhtani
119 schema:givenName Maryam
120 rdf:type schema:Person
121 Nf705923e75654831b0d2643a91bd56c0 schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
127 schema:name Pharmacology and Pharmaceutical Sciences
128 rdf:type schema:DefinedTerm
129 sg:journal.1114785 schema:issn 1381-1991
130 1573-501X
131 schema:name Molecular Diversity
132 rdf:type schema:Periodical
133 https://doi.org/10.1002/(sici)1098-1128(199711)17:6<537::aid-med3>3.0.co;2-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005491171
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1016/0024-3205(75)90501-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032239637
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1016/j.bioorg.2018.03.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101366494
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1016/j.bmcl.2009.06.107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007534061
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1016/j.ejmech.2005.12.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025275759
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1016/j.ejmech.2010.02.063 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024759393
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1016/j.ejmech.2011.09.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036829595
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1016/j.ejmech.2016.01.054 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005941300
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1016/j.farmac.2003.11.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017072338
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1016/j.jksus.2018.02.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101297005
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1016/j.tet.2013.02.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005922223
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/j.tet.2014.07.050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014743949
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/j.tet.2015.06.060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035717697
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/s0014-2999(97)01514-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050401468
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1021/ol1028404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001695760
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1055/s-0032-1317297 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057266376
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1111/j.1600-0404.2008.01004.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014848369
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1179/1743132812y.0000000080 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046589525
168 rdf:type schema:CreativeWork
169 https://doi.org/10.4088/jcp.v64n0107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072208358
170 rdf:type schema:CreativeWork
171 https://www.grid.ac/institutes/grid.411495.c schema:alternateName Babol University of Medical Sciences
172 schema:name Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
173 rdf:type schema:Organization
174 https://www.grid.ac/institutes/grid.411705.6 schema:alternateName Tehran University of Medical Sciences
175 schema:name Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
176 Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
177 Department of Pharmacology, Tehran University of Medical Sciences, Tehran, Iran
178 Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
179 Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
180 rdf:type schema:Organization
181 https://www.grid.ac/institutes/grid.46072.37 schema:alternateName University of Tehran
182 schema:name School of Chemistry, College of Science, University of Tehran, Tehran, Iran
183 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...